T. Rowe Price Associates »

Immunome shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 1.1M 10.70
2023-09-30 $1.5M 174k 8.35
2021-09-30 $263k 11k 24.35

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Immunome

EcoR1 Capital
Redmile Group
Vanguard Group
Henderson Group
Avidity Partners Management
T. Rowe Price Associates
Point72 Asset Management
Brown Advisory Holdings Incorporated
Alpine Partners VI
TD Asset Management
Prentice Capital Management
Jane Street
Laurion Capital Management
Barclays
HPM Partners

View all funds holding Immunome